Evidence map›Paper›PMID 23516318›Full record

ArticleNeurology2013

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation.

Minal J Bhanushali, Sarah M Kranick, Alexandra F Freeman, Jennifer M Cuellar-Rodriguez, Minoo Battiwalla, Juan C Gea-Banacloche, Dennis D Hickstein, Steven Pavletic, Gary Fahle, Avindra Nath

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Central Nervous System Infections in Immunocompromised Patients.Current neurology and neuroscience reports · 2021
    Review
  11. Article
  12. Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Minal J BhanushaliNational Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, Bethesda, MD, USA.
Sarah M Kranick
Alexandra F Freeman
Jennifer M Cuellar-Rodriguez
Minoo Battiwalla
Juan C Gea-Banacloche
Dennis D Hickstein
Steven Pavletic
Gary Fahle
Avindra Nath
National Heart Lung and Blood Institute · USNational Institute of Neurological Disorders and Stroke · USNational Institute of Allergy and Infectious Diseases · US

Funding

NINDS Office of the Clinical DirectorZIDNS003101 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NATH, AVINDRA · 2009 to 2025
$219.6M
Neuropathogenesis of Retroviral InfectionsZIANS003130 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NATH, AVINDRA · 2011 to 2025
$73.7M
Hematopoietic Stem Cell Transplant for Immunodeficiency with MDSZIABC010870 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HICKSTEIN, DENNIS · 2009 to 2025
$18.8M
Allotransplant for DOCK8 deficiencyZIABC011374 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HICKSTEIN, DENNIS · 2011 to 2020
$3.0M
Intramural NIH HHS
6 · The paper itself

Abstract

objectiveTo describe the presentation and management of encephalitis due to human herpes 6 virus (HHV-6) in patients who underwent allogeneic hematopoietic stem cell transplant (alloHSCT), via retrospective chart review.

methodsOf the 243 patients who underwent alloHSCT at the NIH Clinical Center during 2009 to 2011, we retrospectively analyzed 9 diagnosed with HHV-6 encephalitis post-alloHSCT.

resultsEight men and 1 woman (aged 19-60 years) met diagnostic criteria for study inclusion. The median time from HSCT to initial symptoms was 21 days. All patients presented with altered mental status and headaches. Seven patients had amnesia and 2 presented with fever of unknown etiology. Four patients had clinical seizures during the disease course. Brain MRI within 7 days was normal in all patients. Repeat MRI after 7 days showed hyperintensity in the limbic area in 3 patients. On initial testing, CSF analysis indicated acellularity and normal or minimally elevated protein; presence of HHV-6 was detected by PCR. After 7 days, mildly elevated protein and minimal pleocytosis were noted. Ganciclovir, foscarnet, or valganciclovir alone or in combination was initiated with subsequent improvement. Four patients remained alive at 1 year posttransplant; 2 had persistent memory deficits. Presence of encephalitis was associated with higher mortality post-alloHSCT.

conclusionHigh clinical suspicion and CSF PCR testing are important for early diagnosis of HHV-6 encephalitis post-HSCT. Abnormalities on brain MRI or CSF testing may be minimal and delayed. Diagnosis and management of HHV-6 encephalitis is challenging, and a larger prospective study is needed for further research.

Indexed as

Herpesvirus 6, HumanAdultAgedAntiviral AgentsBrainDisease ProgressionFemaleFollow-Up StudiesHeadacheHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedAntiviral Agents

Identifiers

PMID23516318
PMCPMC3662358
OpenAlexW2022000054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.